ALS Trials in Jacksonville, United States
Conditions / ALS / Jacksonville, United States
Research into ALS spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04259255 | Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) | UNKNOWN | — |
| NCT04248465 | An Efficacy and Safety Study of Ravulizumab in ALS Participants | TERMINATED | PHASE3 |
| NCT03268603 | Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06743776 | Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS | AVAILABLE | — |
| NCT04948645 | A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis | TERMINATED | PHASE1 |
| NCT06665165 | AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis | RECRUITING | — |
| NCT00349622 | Clinical Trial Ceftriaxone in Subjects With ALS | COMPLETED | PHASE3 |
| NCT01495390 | A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers | COMPLETED | — |
| NCT04569084 | Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS | TERMINATED | PHASE3 |
| NCT05377424 | Adenosine 2A Receptor Antagonism and AIH in ALS | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |